# Cormorant Asset Management's Pharma Investments: 14 Startups in Its Portfolio (2026) > The 14 Pharma startups Cormorant Asset Management has backed, by stage: $2.6B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/cormorant-asset-management-pharma-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 7 - [Autolus](https://millionrounds.com/company/autolus) - [GH Research](https://millionrounds.com/company/gh-research) - [Edgewise Therapeutics](https://millionrounds.com/company/edgewise-therapeutics) - [Tessera Therapeutics](https://millionrounds.com/company/tessera-therapeutics) - [Interius BioTherapeutics](https://millionrounds.com/company/interius-biotherapeutics) - [Elevation Oncology](https://millionrounds.com/company/elevation-oncology) - [Ventyx Biosciences](https://millionrounds.com/company/ventyx-biosciences) ## Series C and later 4 - [Parabilis Medicines](https://millionrounds.com/company/parabilis-medicines) - [Ovid Therapeutics](https://millionrounds.com/company/ovid-therapeutics) - [Elpiscience Biopharmaceuticals](https://millionrounds.com/company/elpiscience-biopharmaceuticals) - [Umoja Biopharma](https://millionrounds.com/company/umoja-biopharma) ## Series B 3 - [*CT* Crystalys Therapeutics](https://millionrounds.com/company/crystalys-therapeutics) - [Corvus Pharmaceuticals](https://millionrounds.com/company/corvus-pharmaceuticals) - [Rain Oncology](https://millionrounds.com/company/rain-oncology) ## Segment by segment ### Stage not reported 7 startups · $1.1B raised - [**Autolus**](https://millionrounds.com/company/autolus) Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology. United Kingdom $350M - [**GH Research**](https://millionrounds.com/company/gh-research) GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness. Ireland $268M - [**Edgewise Therapeutics**](https://millionrounds.com/company/edgewise-therapeutics) Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization. United States $200M - [**Tessera Therapeutics**](https://millionrounds.com/company/tessera-therapeutics) Tessera Therapeutics, Inc. United States $150M - [**Interius BioTherapeutics**](https://millionrounds.com/company/interius-biotherapeutics) Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas. United States $73M - [**Elevation Oncology**](https://millionrounds.com/company/elevation-oncology) Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients. United States $50M - [**Ventyx Biosciences**](https://millionrounds.com/company/ventyx-biosciences) Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders. United States $27M ### Series C and later 4 startups · $751M raised - [**Parabilis Medicines**](https://millionrounds.com/company/parabilis-medicines) Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines. United States $380M - [**Ovid Therapeutics**](https://millionrounds.com/company/ovid-therapeutics) Ovid Therapeutic's purpose is to solve intractable medical problems. United States $166M - [**Elpiscience Biopharmaceuticals**](https://millionrounds.com/company/elpiscience-biopharmaceuticals) Elpiscience Biopharmaceuticals is a clinical-stage biopharmaceutical company based in Shanghai, China, founded in 2017. China $105M - [**Umoja Biopharma**](https://millionrounds.com/company/umoja-biopharma) Umoja Biopharma is a clinical-stage biotechnology company based in Seattle, Washington, founded in 2019. United States $100M ### Series B 3 startups · $708M raised - [*CT* **Crystalys Therapeutics**](https://millionrounds.com/company/crystalys-therapeutics) United States $335M - [**Corvus Pharmaceuticals**](https://millionrounds.com/company/corvus-pharmaceuticals) Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company. United States $310M - [**Rain Oncology**](https://millionrounds.com/company/rain-oncology) Rain Oncology is a clinical-stage company focusing on research and development of innovative therapies for cancer patients. - $63M **How this map is made.** Every startup here works in Pharma and has raised money in a round we track that names Cormorant Asset Management as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Cormorant Asset Management's Biotech portfolio** 95 startups · $21B](https://millionrounds.com/portfolio-maps/cormorant-asset-management-biotech-portfolio)[Sector portfolio **Cormorant Asset Management's Healthtech portfolio** 12 startups · $1.1B](https://millionrounds.com/portfolio-maps/cormorant-asset-management-healthtech-portfolio)[Portfolio map **Cormorant Asset Management portfolio map** 123 startups · $25B](https://millionrounds.com/portfolio-maps/cormorant-asset-management-portfolio-map)[Co-investors **Who invests with Cormorant Asset Management** 97 co-investors](https://millionrounds.com/portfolio-maps/cormorant-asset-management-co-investors)[Sector portfolio **RA Capital Management's Biotech portfolio** 197 startups · $38B](https://millionrounds.com/portfolio-maps/ra-capital-management-biotech-portfolio)[Sector portfolio **OrbiMed's Biotech portfolio** 176 startups · $28B](https://millionrounds.com/portfolio-maps/orbimed-biotech-portfolio) ## Raising from investors like Cormorant Asset Management? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)